KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Merck's Long-Term Investments rose 9426.09% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 9426.09%. This contributed to the annual value of $463.0 million for FY2024, which is 8373.02% up from last year.
  • Latest data reveals that Merck reported Long-Term Investments of $1.1 billion as of Q3 2025, which was up 9426.09% from $774.0 million recorded in Q2 2025.
  • Over the past 5 years, Merck's Long-Term Investments peaked at $1.3 billion during Q3 2023, and registered a low of $238.0 million during Q2 2022.
  • Its 5-year average for Long-Term Investments is $660.9 million, with a median of $544.0 million in 2021.
  • Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 102121.21% in 2021, then tumbled by 7829.46% in 2024.
  • Merck's Long-Term Investments (Quarter) stood at $370.0 million in 2021, then skyrocketed by 174.32% to $1.0 billion in 2022, then tumbled by 75.17% to $252.0 million in 2023, then skyrocketed by 83.73% to $463.0 million in 2024, then skyrocketed by 141.25% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $774.0 million for Q2 2025, and $616.0 million during Q1 2025.